Search
HUTCHMED (China) Ltd
HCMAdd to Watchlist
10.780USD
+0.020+0.19%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.87BMarket Cap
19.94P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
10
analysts
Buy
Current Rating
21.525
Target Price
+100.05%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
HUTCHMED (China) Ltd
HCM
10
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is HUTCHMED (China) Ltd's price target?
Analysts forecast that HUTCHMED (China) Ltd's price target is USD 20.00, with the highest forecast at USD 40.40 and the lowest forecast at USD 6.47.
What is the analyst rating for HUTCHMED (China) Ltd?
Based on the ratings of HUTCHMED (China) Ltd's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.